Buffer S9b Solution for suspension for injection
217023
Phase 2 small_molecule active
Quick answer
Buffer S9b Solution for suspension for injection for Hepatitis B, Chronic is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Hepatitis B, Chronic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active